Eastman Chemical (NYSE:EMN - Free Report) - Equities researchers at Zacks Research decreased their Q2 2025 earnings per share estimates for shares of Eastman Chemical in a report released on Tuesday, April 8th. Zacks Research analyst R. Department now expects that the basic materials company will earn $2.20 per share for the quarter, down from their previous forecast of $2.23. The consensus estimate for Eastman Chemical's current full-year earnings is $8.55 per share. Zacks Research also issued estimates for Eastman Chemical's Q4 2025 earnings at $1.94 EPS and FY2025 earnings at $8.30 EPS.
EMN has been the subject of several other research reports. StockNews.com raised shares of Eastman Chemical from a "hold" rating to a "buy" rating in a research note on Saturday, January 18th. Wells Fargo & Company dropped their target price on shares of Eastman Chemical from $125.00 to $90.00 and set an "overweight" rating for the company in a report on Wednesday, April 9th. Citigroup raised shares of Eastman Chemical from a "neutral" rating to a "buy" rating and lowered their price objective for the company from $105.00 to $101.00 in a research note on Friday, April 4th. Royal Bank of Canada raised Eastman Chemical from a "sector perform" rating to an "outperform" rating and set a $91.00 target price for the company in a research note on Wednesday, April 9th. Finally, Mizuho upgraded shares of Eastman Chemical from a "neutral" rating to an "outperform" rating and set a $105.00 price objective on the stock in a report on Thursday, April 3rd. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat.com, Eastman Chemical has an average rating of "Moderate Buy" and an average price target of $107.08.
Get Our Latest Stock Analysis on Eastman Chemical
Eastman Chemical Price Performance
EMN traded up $0.46 on Wednesday, reaching $78.81. 347,682 shares of the company's stock were exchanged, compared to its average volume of 1,009,269. The stock's fifty day moving average price is $92.01 and its 200-day moving average price is $97.13. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.51 and a quick ratio of 0.78. The stock has a market cap of $9.08 billion, a PE ratio of 10.26, a P/E/G ratio of 1.22 and a beta of 1.38. Eastman Chemical has a twelve month low of $70.90 and a twelve month high of $114.50.
Eastman Chemical (NYSE:EMN - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The basic materials company reported $1.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.27. Eastman Chemical had a return on equity of 16.27% and a net margin of 9.65%.
Eastman Chemical Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, April 7th. Investors of record on Friday, March 14th were given a dividend of $0.83 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $3.32 dividend on an annualized basis and a yield of 4.21%. Eastman Chemical's dividend payout ratio (DPR) is presently 43.23%.
Institutional Trading of Eastman Chemical
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Crews Bank & Trust bought a new stake in Eastman Chemical during the 4th quarter worth about $27,000. Picton Mahoney Asset Management raised its position in Eastman Chemical by 62.3% in the 4th quarter. Picton Mahoney Asset Management now owns 323 shares of the basic materials company's stock valued at $29,000 after buying an additional 124 shares during the last quarter. Assetmark Inc. increased its stake in Eastman Chemical by 384.4% in the 4th quarter. Assetmark Inc. now owns 373 shares of the basic materials company's stock valued at $34,000 after buying an additional 296 shares during the last quarter. Bradley & Co. Private Wealth Management LLC bought a new position in Eastman Chemical in the fourth quarter valued at approximately $35,000. Finally, Stonebridge Financial Group LLC bought a new stake in Eastman Chemical during the fourth quarter worth $37,000. 83.65% of the stock is currently owned by institutional investors and hedge funds.
Eastman Chemical Company Profile
(
Get Free Report)
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.
See Also

Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.